Kenpallone (9-bromo-7, 12-dihydroindolo[3, 2-d][1]benzazepin-6(5H)-one), a cyclin-dependent kinases (Cdks)/glycogen synthase kinase 3 (GSK-3) inhibitor, showed the most significant activity in this screen. a Cdk/GSK-3 inhibitor, kenpaullone, and two Cdk inhibitors, olomoucine and roscovitine, as activators of osteoclastogenesis. The kenpaullone, olomoucine, and roscovitine induce an enhanced osteoclastogenesis by upregulating NFATc1 and mature cathepsin K levels. == 1 . Introduction == Bone homeostasis is tightly controlled by osteoblasts and osteoclasts which are involved in bone formation and resorption, respectively[1],[2],[3]. The imbalance between bone formation and resorption leads to impaired bone remodeling and development of bone disorders. Enhanced bone resorption by osteoclasts weakens bone structure and can cause osteoporosis over time whereas defects in the function of osteoclasts lead to osteopetrosis[1]. Osteoclasts are giant multinucleated cells derived from monocyte/macrophage lineage precursor cells through the differentiation process primarily induced by two cytokines, macrophage colony-stimulating factor (M-CSF) and Rabbit Polyclonal to ATP5I receptor activator of nuclear factor B ligand (RANKL), which are produced by osteoblasts[4]. The M-CSF supports proliferation and survival of osteoclast precursor cells, and upregulates RANK expression. The RANKL and RANK interaction recruits adaptor protein TRAF6, which in turn assembles with TAB2-TAK1 to activate mitogen-activated kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), Jun N-terminal kinase (JNK), and p38 as well as NF-B pathways[5]. NF-B is required intended for initial induction of NFATc1, a key transcription factor intended for osteoclast differentiation. Then, MAPKs activate AP-1 (c-Fos/c-Jun), that further amplifies NFATc1[6]. The activity of NFATc1 is regulated by calcium signaling that is induced by activation of the immunoglobulin-like receptors associated with the immunoreceptor tyrosine-based activation motif (ITAM)-harboring adaptor proteins, including DAP12 and FcR[7]. The activated calcineurin dephosphorylates NFATc1, which subsequently translocates to nucleus and cooperatively induces osteoclast-related genes with other transcription factors such as MITF, PU. 1, CREB, and AP-1[8]. Thus, the RANKRANKL signaling activates various downstream signaling pathways required for the osteoclastogenesis[9]. Recent studies have significantly advanced our knowledge about the regulatory mechanism of osteoclastogenesis pathway, but the whole osteoclastic signaling network is yet unknown. Therefore , we performed a chemical genetic screen to identify novel pathways and factors which controls osteoclastogenesis by using annotated small compounds LOPAC1280(Sigma). Our screen identified a Cdk/GSK-3 inhibitor, kenpaullone, and two Cdk inhibitors, olomoucine and roscovitine, as activators of the osteoclastogenesis. Our data showed that the inhibition of Cdks and/or GSK3- significantly upregulates NFATc1 and subsequently enhances the formation of functional osteoclasts. == 2 . Material and methods == == 2 . 1 . Cells and reagents == For the osteoclastogenic culture, RAW264. 7 and pNFAT/Luc-RAW cells were cultured in -MEM medium containing 10% fetal bovine serum (FBS), 100 ng/ml soluble RANKL (sRANKL, Peprotech and Oriental Yeast), 2 mMl-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin[10]. Intended for osteoclast formation by using primary pre-osteoclast cultures, murine bone marrow cells were LY 345899 obtained from femurs and LY 345899 tibiae of 7-week-old ddY mice (Japan SLC, Inc. ). 4. 0105cells were cultured in -MEM LY 345899 medium containing 10% fetal bovine serum (FBS), 100 ng/ml sRANKL, 10 ng/ml M-CSF (Wako, JPN), 2 mMl-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin in 24-well plates. Kenpaullone (Sigma), olomoucine (Sigma), roscovitine (Sigma) are used at a final concentration of 50 nM. The culture medium in each well was replaced by fresh medium that contains M-CSF and sRANKL every 2 days. TRAP LY 345899 staining was performed after 5 days of the induction. == 2 . 2 . Cell-based screening of the small-compound library == The pNFAT/Luc-RAW cells were used for screen small compounds, LOPAC1280(Sigma) that contains 1280 compounds of marketed drugs and pharmaceutically relevant structural derivatives. These compounds are annotated with biological activities and classified as follows: cell signaling (9%), phosphorylation (8%), cell stress (4%), lipids (4%), ion channels (6%), G proteins (3%), apoptosis/cell cycle (2%), gene regulation (3%), hormone related (3%), and neuroscience related (58%). The pNFAT/Luc-RAW cells (5000 cells/well) were plated into 96-well plates in 100 l of -MEM medium with 10% FBS, 2 mMl-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin. The culture medium was exchanged the next day intended for fresh medium containing sRANKL (100 ng/ml), followed by the addition of each compound in the library to the cells at 10 M. The luciferase activity of each well was measured after 24 h using the ONEGlo luciferase LY 345899 assay system (Promega) and a microplate reader (GloMax-Multi Detection System, Promega). == 2 . a few..